| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/1999 | WO1999035146A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/15/1999 | WO1999035145A1 Deprotection and recrystallization processes |
| 07/15/1999 | WO1999035144A1 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 07/15/1999 | WO1999035143A1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same |
| 07/15/1999 | WO1999035135A1 Hypolipidemic benzothiazepine compounds |
| 07/15/1999 | WO1999035131A1 Aryl fused azapolycyclic compounds |
| 07/15/1999 | WO1999035130A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/15/1999 | WO1999035129A1 Succinimide derivatives which inhibit retinoic acid metabolism |
| 07/15/1999 | WO1999035125A1 Alpha-aminoamide derivatives useful as analgesic agents |
| 07/15/1999 | WO1999035124A1 Matrix metalloprotease inhibitors |
| 07/15/1999 | WO1999035123A1 Substituted 2-benzylamino-2-phenyl-acetamide compounds |
| 07/15/1999 | WO1999035116A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| 07/15/1999 | WO1999034837A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/15/1999 | WO1999034832A1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
| 07/15/1999 | WO1999034831A1 Enhanced transport using membrane disruptive agents |
| 07/15/1999 | WO1999034830A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | WO1999034813A1 Supplement for dialysis patients |
| 07/15/1999 | WO1999034809A1 Solid iodophor preparations and process for producing the same |
| 07/15/1999 | WO1999034808A1 Use of extracts of geraniine geranium or related compounds for preparing analgesic medicines of central non-morphine type |
| 07/15/1999 | WO1999034807A1 Pharmaceutical composition comprising clioquinol and vitamin b¿12? |
| 07/15/1999 | WO1999034806A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA) |
| 07/15/1999 | WO1999034805A1 Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection |
| 07/15/1999 | WO1999034804A1 A2a adenosine receptor agonists |
| 07/15/1999 | WO1999034803A1 Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury |
| 07/15/1999 | WO1999034802A1 Use of phenylthienylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of depression |
| 07/15/1999 | WO1999034801A1 Use of diphenylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of depression |
| 07/15/1999 | WO1999034800A1 Use of phenylthienylmethylene piperidine derivative in the manufacture of a medicament for the treatment of movement disorders |
| 07/15/1999 | WO1999034799A1 Use of diphenylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of movement disorders |
| 07/15/1999 | WO1999034798A1 Method for treating copd |
| 07/15/1999 | WO1999034797A1 Method for treating multiple sclerosis |
| 07/15/1999 | WO1999034796A1 Synergistic antitumor composition containing a naphthalensulphonic acid derivative |
| 07/15/1999 | WO1999034794A1 Methods for treating diabetic dyslipidemia using tocotrienols |
| 07/15/1999 | WO1999034793A1 Pyronin antibacterials, process and novel intermediates thereto |
| 07/15/1999 | WO1999034792A1 Use of mek1 inhibitors as protective agents against damage due to ischemia |
| 07/15/1999 | WO1999034791A1 Methods and compositions for inactivating viruses |
| 07/15/1999 | WO1999034789A1 Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host |
| 07/15/1999 | WO1999034788A1 Synthesis of phenstatin and prodrugs thereof |
| 07/15/1999 | WO1999034787A2 Fat-binding polymers |
| 07/15/1999 | WO1999034786A2 Lipase inhibiting polymers |
| 07/15/1999 | WO1999034785A2 Treatment of dyskinesias |
| 07/15/1999 | WO1999034784A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034783A1 USE OF PPAR-η ACTIVATORS IN DERMATOLOGY |
| 07/15/1999 | WO1999034782A1 Tts containing an antioxidant |
| 07/15/1999 | WO1999034779A1 Magnetically responsive composition |
| 07/15/1999 | WO1999034778A1 A method for making a pharmaceutical formulation |
| 07/15/1999 | WO1999034776A1 Nasal drop compositions |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034751A1 A drug dosage form based on the teorell-meyer gradient |
| 07/15/1999 | WO1999034676A1 Method of synthesis of derivatives of aloesin |
| 07/15/1999 | WO1999034675A1 Promoting mobilization and catabolism of lipids |
| 07/15/1999 | WO1999026584A3 Inhibitors of gap junction communication |
| 07/15/1999 | WO1999025716A3 Pyranones, method for the production and use thereof |
| 07/15/1999 | WO1999024391B1 Radio-opaque polymer biomaterials |
| 07/15/1999 | WO1999024027A3 Anti-estrogen plus progestin containing oral contraceptives |
| 07/15/1999 | WO1999024026A3 Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds |
| 07/15/1999 | WO1999024023A3 FORMULATION OF A COMBINATION COMPRISED OF OPIOID AND α - ADRENERGIC AGONISTS AND THE APPLICATION THEREOF |
| 07/15/1999 | WO1999015179A9 Methods of limiting apoptosis of cells |
| 07/15/1999 | DE19813759C1 Inducing a natural killer cell immune response ex vivo |
| 07/15/1999 | DE19800812A1 Effervescent oral composition containing L-arginine, as nutrient and for treating heart disease and hypercholesterolemia |
| 07/15/1999 | DE19800214A1 Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür Process for the preparation of doxazosin Mcsylat in a crystal form known as Form A and an intermediate therefor |
| 07/15/1999 | CA2324972A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | CA2318417A1 Fat-binding polymers |
| 07/15/1999 | CA2318416A1 Polymers comprising lipase inhibiting groups |
| 07/15/1999 | CA2318369A1 Recombinant, active caspases and uses thereof |
| 07/15/1999 | CA2318218A1 Methods for treating diabetic dyslipidemia using tocotrienols |
| 07/15/1999 | CA2317951A1 Novel aromatic amides, preparation method and application as medicines |
| 07/15/1999 | CA2317811A1 Treatment of dyskinesias |
| 07/15/1999 | CA2317720A1 Method for treating copd |
| 07/15/1999 | CA2317718A1 Deprotection and recrystallization processes |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2317651A1 Hypolipidemic benzothiazepine compounds |
| 07/15/1999 | CA2317587A1 Solid iodophor preparations and process for producing the same |
| 07/15/1999 | CA2317548A1 Method for treating multiple sclerosis |
| 07/15/1999 | CA2317523A1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same |
| 07/15/1999 | CA2317458A1 Methods and compositions for inactivating viruses |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2317093A1 A2a adenosine receptor agonists |
| 07/15/1999 | CA2317010A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | CA2316863A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/15/1999 | CA2315736A1 Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus |
| 07/15/1999 | CA2315708A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | CA2315265A1 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | CA2315156A1 Pyronin antibacterials, process and novel intermediates thereto |
| 07/15/1999 | CA2314510A1 Synthesis of phenstatin and prodrugs thereof |
| 07/15/1999 | CA2312867A1 Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury |
| 07/15/1999 | CA2282596A1 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 07/15/1999 | CA2278487A1 Process for preparing carboxamido-4-azasteroids |
| 07/15/1999 | CA2256793A1 New compound intended by way of oromucous membrane notably pernasal |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928793A1 Thiazole derivatives |
| 07/14/1999 | EP0928792A2 Bicyclic(3.1.0)hexanes and related compounds |
| 07/14/1999 | EP0928790A1 Thiazole derivatives |
| 07/14/1999 | EP0928788A1 Imidazolidin-4-one derivatives useful as anticancer agents |
| 07/14/1999 | EP0928787A1 Process for the preparation of 3-amino-pyrrolidine derivatives |
| 07/14/1999 | EP0928609A2 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/14/1999 | EP0928522A2 Method for adapting a receiver to transmission conditions, and the adequate receiver |
| 07/14/1999 | EP0928336A1 Chaperone fragments |
| 07/14/1999 | EP0928335A2 METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CpG DINUCLEOSIDES |
| 07/14/1999 | EP0928301A1 Fluid composition for physiological separations |